Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Yongsheng Chan

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Cancer Letters|July 21, 2009
Spontaneous and 5-fluorouracil-induced centrosome amplification lowers the threshold to resveratrol-evoked apoptosis in colon cancer cellsShao Chin Lee, Jason Yongsheng Chan, Shazib Pervaiz
Expert Review of Molecular Diagnostics|April 4, 2015
Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challengesJason Yongsheng Chan, Yukti Choudhury, Min-Han Tan
Journal of Gastrointestinal Oncology|July 11, 2026
Interpreting ctDNA dynamics in gastrointestinal stromal tumor (GIST) therapy-timing may be keyJing Yi Lee, Tun Kiat Ko, Jason Yongsheng Chan
Precision Clinical Medicine|June 13, 2022
Checkpoint immunotherapy for NK/T cell lymphoma-Time for a showdown?Jason Yongsheng Chan, Jing Quan Lim, Choon Kiat Ong
Life (Basel, Switzerland)|August 27, 2021
Towards Next Generation Biomarkers in Natural Killer/T-Cell LymphomaJason Yongsheng Chan, Jing Quan Lim, Choon Kiat Ong
Diagnostics (Basel, Switzerland)|August 10, 2024
Cutaneous Adverse Reactions and Survival Outcomes of Advanced Melanoma Treated with Immune Checkpoint Inhibitors in an Academic Medical Centre in SingaporeAgnes Yeok-Loo Lim, Jason Yongsheng Chan, Choon Chiat Oh
Journal of Hematology & Oncology|June 2, 2024
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphomaEsther Wei Yin Chang, Ya Hwee Tan, Jason Yongsheng Chan
Anticancer Research|August 8, 2009
Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activationJason Yongsheng Chan, Benny Kwong Huat Tan, Shao Chin Lee
Journal of Hematology|September 4, 2025
Clinical Patterns and Prognostic Outcomes of Asian Ocular Adnexal Marginal Zone LymphomaRowena Lee Ying Kwan, Ryan Mao Heng Lim, Jason Yongsheng Chan
Therapeutic Advances in Medical Oncology|November 3, 2023
Classification of HER2-negative breast cancers by <i>ERBB2</i> copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrationsJui Wan Loh, Abner Herbert Lim, Jason Yongsheng Chan, et al.
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Cancer Letters|July 21, 2009
Spontaneous and 5-fluorouracil-induced centrosome amplification lowers the threshold to resveratrol-evoked apoptosis in colon cancer cellsShao Chin Lee, Jason Yongsheng Chan, Shazib Pervaiz
Expert Review of Molecular Diagnostics|April 4, 2015
Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challengesJason Yongsheng Chan, Yukti Choudhury, Min-Han Tan
Journal of Gastrointestinal Oncology|July 11, 2026
Interpreting ctDNA dynamics in gastrointestinal stromal tumor (GIST) therapy-timing may be keyJing Yi Lee, Tun Kiat Ko, Jason Yongsheng Chan
Precision Clinical Medicine|June 13, 2022
Checkpoint immunotherapy for NK/T cell lymphoma-Time for a showdown?Jason Yongsheng Chan, Jing Quan Lim, Choon Kiat Ong
Life (Basel, Switzerland)|August 27, 2021
Towards Next Generation Biomarkers in Natural Killer/T-Cell LymphomaJason Yongsheng Chan, Jing Quan Lim, Choon Kiat Ong
Diagnostics (Basel, Switzerland)|August 10, 2024
Cutaneous Adverse Reactions and Survival Outcomes of Advanced Melanoma Treated with Immune Checkpoint Inhibitors in an Academic Medical Centre in SingaporeAgnes Yeok-Loo Lim, Jason Yongsheng Chan, Choon Chiat Oh
Journal of Hematology & Oncology|June 2, 2024
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphomaEsther Wei Yin Chang, Ya Hwee Tan, Jason Yongsheng Chan
Anticancer Research|August 8, 2009
Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activationJason Yongsheng Chan, Benny Kwong Huat Tan, Shao Chin Lee
Journal of Hematology|September 4, 2025
Clinical Patterns and Prognostic Outcomes of Asian Ocular Adnexal Marginal Zone LymphomaRowena Lee Ying Kwan, Ryan Mao Heng Lim, Jason Yongsheng Chan
Therapeutic Advances in Medical Oncology|November 3, 2023
Classification of HER2-negative breast cancers by <i>ERBB2</i> copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrationsJui Wan Loh, Abner Herbert Lim, Jason Yongsheng Chan, et al.
Pageof 14